Jean Hurley2 min read
Jean Hurley39 min listen
GRIP3 min read

The regulator is allowing the pharma giant’s revised biologics licensed application to proceed to review.
Kevin Kinsella2 min read

The FDA issued an extremely rare refuse-to-file letter related to Moderna’s new mRNA flu vaccine.
Kevin Kinsella4 min read

The federal regulator contends the four biologics firms lack appropriate testing and marketing authorization.
Kevin Kinsella2 min read